New strategy for the DKMA

The Danish Medicines Agency has formulated a new strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme

Vaccines for children

In July 2021, the first corona vaccine was introduced in Denmark for children aged 12-15 years. The EU Commission has also approved the vaccine for the smaller children aged 5-11 years. Read about the difference between vaccines for children and adults, and how the authorisation takes place.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2


Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.


New executive order raises fees in the area of the Danish Medicines Agency

03 May 2022

Higher fees become payable for medicinal products and pharmaceutical companies as a result of a new executive order entering into force on 1 May 2022. The last time the fees were adjusted was in 2017.

Danish Medicines Agency presents new strategy

05 April 2022

2021 deadline for submitting applications concerning marketing authorisations and clinical trials

08 November 2021

Danish Medicines Agency investigates a case of inflammatory condition reported after COVID-19 vaccination

26 August 2021